Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy
Table 4
Comparison of the TCM syndrome score at the baseline and after TFS treatment.
Category
Time (Week)
mean(SD)
Min, Max
T test(P)
TCM syndrome
baseline
5.15(2.20)
0, 15
—
3
4.51(2.35)
0, 13
-14.36(<0.0001)
8/9
3.84(2.10)
0, 13
-22.25(<0.0001)
Weight
baseline
60.59(8.79)
41, 105
—
3
63.58(9.79)
41, 105
0.28(0.7568)
8/9
64.25(9.25)
41, 105
3.26(0.0023)
ECOG
baseline
—
—
—
3
-0.04(0.28)
-1,1
-436.0(0.0035)
8/9
-0.05(0.32)
-1,1
-767.5(0.0013)
FACT-L (Physiology)
baseline
18.67(4.56)
3, 26
—
3
0.25(2.45)
-10, 17
3.25(0.0015)
8/9
1.02(3.62)
-10, 17
7.85(<0.0001)
FACT-L (Social/Family )
baseline
17.23(3.45)
6, 27
—
3
17.98(3.89)
6, 29
1.08(0.2645)
8/9
18.15(3.87)
5, 28
5.56(<0.0001)
FACT-L (Emotion )
baseline
14.23(3.87)
0, 28
—
3
14.89(3.98)
2, 24
6.12(<0.0001)
8/9
15.23(4.33)
3, 27
9.87(<0.0001)
FACT-L (Function)
baseline
14.23(5.45)
0,28
—
3
15.76(5.25)
0,29
6.23(<0.0001)
8/9
16.56(5.65)
0,29
11.56(<0.0001)
FACT-L (Pain)
baseline
0.87(1.08)
0,8
—
3
0.86(0.78)
0,6
-4.56(0.0005)
8/9
0.87(1.21)
0,21
-4.78(<0.0001)
FACT-L (Additional attention)
baseline
22.45(5.12)
4,36
—
3
24.56(5.12)
4,37
6.67(<0.0001)
8/9
26.78(5.02)
4,37
10.12(<0.0001)
Signed rank sum test. TCM syndrome: traditional Chinese medicine syndrome; ECOG: Eastern Cooperative Oncology Group; FACT-L: Functional Assessment of Cancer Therapy-Lung.
